PRINCETON, N.J., June 11, 2018 /PRNewswire/ -- Calyptus Pharmaceuticals Inc. ("Calyptus"), a private pharmaceutical companyfocused on the needs of hospitals, community clinics, specialty and retail pharmacies, today announced the appointment of Amit Patel to its Board of Directors.
Sujeet Singh, CEO of
Commenting on his appointment, Amit said, "I welcome the opportunity to join the Calyptus Board at the early stages of the company's growth potential. I look forward to helping advance Calyptus' mission and supporting the interests of its customers, colleagues, partners and investors."
Founded in 2017, Calyptus is developing a portfolio of sterile products (generic ANDAs and specialty 505(b)2s) that resolve technological complexity, create accelerated regulatory pathways, bridge unmet medical needs and overcome market access barriers.
ABOUT CALYPTUS PHARMACEUTICALS
Calyptus Pharma is a pharmaceutical company whose mission is to improve lives of patients by increasing access and affordability of quality medicines.
Calyptus Pharmaceuticals Inc. Empowering Healthcare
CONTACT Name: Shubhayu Sinharoy, COO Email: email@example.com Phone: 269-873-0430 Website: www.calyptuspharma.com
View original content:http://www.prnewswire.com/news-releases/calyptus-pharma-appoints-amit-patel-to-board-of-directors-300663947.html
SOURCE Calyptus Pharmaceuticals
Subscribe to our Free Newsletters!
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...View All